25I-NBOMe deluje kao visokopotentan punagonist ljudskog5-HT2Areceptora,[6][7] saKi od 0,044 nM, te je šesnaest puta potentniji od 2C-I liganda.Radio obeležena forma 25I-NBOMe se može koristiti za mapiranje distribucije 5-HT2A receptora u mozgu.[8]In vitro testovi su pokazali da ovo jedinjenje deluje kao agonist, ali rezultati životinjskih studija nisu objavljeni. DokN-benzilni derivati 2C-I znatno povećavaju potentnost,N-benzilni derivati2,5-dimetoksi-4-jodoamfetamina su neaktivni.[9]
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Ettrup, A.et al. (2010). „Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers”. European Journal of Nuclear Medicine and Molecular Imaging38 (4): 681–693. DOI:10.1007/s00259-010-1686-8. PMID21174090.
↑Silva ME, Heim R, Strasser A, Elz S, Dove S (January 2011). „Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor”. Journal of Computer-aided Molecular Design25 (1): 51–66. DOI:10.1007/s10822-010-9400-2. PMID21088982.